Physician profile
Christopher Todd King
NPI 1548333271
$1,960.23
in general payments reported to CMS, 2019-2025
11 companies · $382 in 2025
The $382 reported for 2025 was more than what 87% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $726 · 2020: $116 · 2021: $180 · 2023: $167 · 2024: $389 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $827 · Food and Beverage: $81.27 · Honoraria: $29.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $827.25 |
| Food and Beverage | $81.27 |
| Honoraria | $29.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Benco Dental Supply Co. | $809.88 | 2019-2024 | |
| Ultradent Products INC | $741.39 | 2024-2025 | Opalescence |
| Align Technology, INC. | $226.61 | 2020-2021 | |
| Biohorizons Implant Systems INC. | $40.95 | 2019-2023 | Biohorizons |
| Voco America INC. | $28.90 | 2020-2023 | Meron Plus Qm, Voco Profluorid Varnish, Futurabond U |
| Dentsply Sirona INC | $28.68 | 2021 | |
| 3m Company | $26.53 | 2019-2021 | |
| Orapharma, A Division of Bausch Health US, LLC | $15.98 | 2023 | Arestin |
| Nobel Biocare USA | $14.09 | 2023 | Nobelactive |
| Kerr Corporation | $14.08 | 2023 | Harmonize |
| Hu-Friedy Mfg. Co., LLC | $13.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.